Effect of Silymarin and Quercetin in a Miniaturized Scaffold in Wistar Rats against Non-alcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

Effect of Silymarin and Quercetin in a Miniaturized Scaffold in Wistar Rats against Non-alcoholic Fatty Liver Disease

Published:2021-08-03 Issue:32 Volume:6 Page:20735-20745
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Stephen Robert Jaisheela Marry¹²^ORCID,Peddha Muthukumar Serva³²^ORCID,Srivastava Alok Kumar¹²

Affiliation:

1. Department of Food Safety and Analytical Quality Control Laboratory, CSIR- Central Food Technological Research Institute, Mysuru, Karnataka 570 020, India

2. Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India

3. Department of Biochemistry, CSIR- Central Food Technological Research Institute, Mysuru, 570 020 Karnataka, India

Funder

Indian Council of Medical Research

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.1c00555

Reference44 articles.

1. Cytochrome P450-mediated metabolism in the human gut wall

2. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

3. Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases

4. Treatment of non-alcoholic fatty liver disease

5. Serum Retinol-binding Protein 4 Levels in Patients With Nonalcoholic Fatty Liver Disease

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-alcoholic fatty liver disease: Dietary and nutraceutical approaches;Liver Research;2023-09

2. Silymarin, an antioxidant flavonoid, protects the liver from the toxicity of the anticancer drug paclitaxel;Tissue and Cell;2023-08

3. Challenges and opportunities for improving the druggability of natural product: Why need drug delivery system?;Biomedicine & Pharmacotherapy;2023-08

4. Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy;World Journal of Hepatology;2023-02-27

5. The Preventive and Therapeutic Potential of the Flavonoids in Liver Cirrhosis: Current and Future Perspectives;Chemistry & Biodiversity;2023-01-26